These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2495678)

  • 1. Effect of temporary IL-2 receptor MAB therapy on islet allograft in autoimmune diabetes.
    Hahn HJ; Kuttler B; Lucke S; Dunger A; Besch W; Volk HD; Diamankstein T
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2711-3. PubMed ID: 2495678
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin 2 receptor-targeted therapy in islet transplantation research.
    Hahn HJ; Kuttler B; Volk HD; Lucke S; Diamantstein T
    Horm Metab Res Suppl; 1990; 25():177-80. PubMed ID: 2088963
    [No Abstract]   [Full Text] [Related]  

  • 3. Temporary anti-CD-25 treatment results in tolerance development in syngeneically grafted autoimmune diabetic recipients.
    Hahn HJ; Kuttler B; Dunger A; Lucke S; Volk HD; Diamantstein T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):741-2. PubMed ID: 1990673
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic consequences of islet MHC antigen modulation in autoimmune diabetes.
    Markmann JF; Posselt AM; Levy M; Naji A; Barker CF
    Transplant Proc; 1990 Apr; 22(2):849-50. PubMed ID: 2109417
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of anti-interleukin-2 receptor antibody treatment on recurrent autoimmune insulitis in the BB rat.
    Woehrle M; Pullmann J; Stuenkel KG; Bretzel RG; Federlin K
    Transplant Proc; 1994 Apr; 26(2):734-5. PubMed ID: 8171631
    [No Abstract]   [Full Text] [Related]  

  • 6. Interleukin 2 receptor targeted immunotherapy in the prevention of autoimmune beta-cell destruction as observed in diabetic BB/OK rats grafted with BB/OK rat islets.
    Hahn HJ; Kauert C; Dunger A; Kuttler B; Diamantstein T
    Autoimmunity; 1989; 5(1-2):139-42. PubMed ID: 2519014
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of autoimmune damage to islet grafts in BB rats by antibody therapy.
    Markmann JF; Jacobson J; Kimura H; Brayman KL; Barker CF; Naji A
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2703-4. PubMed ID: 2495674
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of islet graft destruction in diabetic mice and rats by temporary anti-IL-2 receptor therapy: comparison of different strategies.
    Kuttler B; Mathieu C; Bulfone-Paus S; Bouillon R; Diamantstein T; Hahn HJ
    Transplant Proc; 1998 Dec; 30(8):4140-2. PubMed ID: 9865327
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrathymic islet allografts prevent hyperglycemia and autoimmune beta-cell destruction in BB rats following transplantation in the prediabetic period.
    Brayman KL; Nakai I; Field J; Lloveras JJ; Farney A; Najarian JS; Sutherland DE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):284-5. PubMed ID: 8438301
    [No Abstract]   [Full Text] [Related]  

  • 10. Streptozotocin-diabetic BB/OK rats accept permanently BB/OK-islet grafts without immunosuppression.
    Hahn HJ; Ziegler B; Lucke S
    Z Versuchstierkd; 1989; 32(3):135-40. PubMed ID: 2528866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypical characterization of the cells invading pancreatic islets of diabetic BB/OK rats: effect of interleukin 2 receptor-targeted immunotherapy.
    Hahn HJ; Gerdes J; Lucke S; Liepe L; Kauert C; Volk HD; Wacker HH; Brocke S; Stein H; Diamantstein T
    Eur J Immunol; 1988 Dec; 18(12):2037-42. PubMed ID: 3065088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats.
    Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T
    Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of transplant site on islet allograft survival in BB rats.
    Woehrle MF; Markmann JF; Armstrong J; Naji A
    Transplant Proc; 1987 Feb; 19(1 Pt 2):925-7. PubMed ID: 3152638
    [No Abstract]   [Full Text] [Related]  

  • 14. No correlation between changes in lymphocyte subsets and pancreatic B cell destruction.
    Kuttler B; Heym S; Volk HD; Diamantstein T; Hahn HJ
    Horm Metab Res Suppl; 1990; 25():182-7. PubMed ID: 2088964
    [No Abstract]   [Full Text] [Related]  

  • 15. Transplantation of cultured pancreatic islets to BB rats.
    Woehrle M; Markmann JF; Silvers WK; Barker CF; Naji A
    Surgery; 1986 Aug; 100(2):334-41. PubMed ID: 3090724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptozotocin-induced hyperglycemia in rats: analysis of complement activity after streptozotocin administration.
    Perloff JR; Levy MM; Ketchum RJ; Read AD; White D; Brayman KL
    Transplant Proc; 1995 Dec; 27(6):3399. PubMed ID: 8540017
    [No Abstract]   [Full Text] [Related]  

  • 17. Potent immunosuppressive effect of anti-LFA-1 monoclonal antibody on islet allograft rejection.
    Nishihara M; Gotoh M; Fukuzaki T; Ohta Y; Monden M; Yagita H; Okumura K; Miyasaka M; Mori T
    Transplant Proc; 1995 Feb; 27(1):372. PubMed ID: 7879025
    [No Abstract]   [Full Text] [Related]  

  • 18. Islet transplantation in autoimmune diabetes mellitus.
    Weber C; Ting W; Rosenkrantz K; Rivera S; Pernis B; Reemtsma K
    Transplant Proc; 1984 Jun; 16(3):845-8. PubMed ID: 6428008
    [No Abstract]   [Full Text] [Related]  

  • 19. Islet transplantation to study autoimmune pathogenesis of diabetes in BB rat.
    Markmann JF; Woehrle M; Roza A; Barker CF; Naji A
    Horm Metab Res Suppl; 1990; 25():116-9. PubMed ID: 2088949
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful islet transplantation in BB rats without chronic immunosuppression.
    Chabot JA; Lau H; Reemtsma K; Hardy MA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):974-5. PubMed ID: 3152652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.